Smart infant monitors: a pediatrician’s guide
An overview of commercially available infant cardiorespiratory monitors and pulse oximeters in the home.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA approves neffy 1 mg for anaphylaxis in children aged 4 years and older
The newly-approved indication is for children aged 4 years and older who weigh 33 < 66 lbs, expanding on the August 9, 2024 approval in children at least 66 lbs.
Demystifying Infant Formula
The pediatric mental health crisis: A call to action for pediatricians
Mike Hennessy Jr, President and CEO of MJH Life Sciences kicks off our March Mental Health issue with a look into the ongoing pediatric mental health crisis.
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis
First approved for PNH in 2007, the monoclonal antibody is now the first and only treatment for pediatric patients living with gMG.
